Personalised indication of augmentation therapy for emphysema associated with severe alpha-1 antitrypsin deficiency: a case series [PDF]
Severe alpha-1 antitrypsin deficiency (AATD) is associated with an increased risk of emphysema. However, the clinical manifestations are very heterogeneous, and an individual prognosis is very difficult to establish. Intravenous augmentation therapy with
Cristina Aljama +4 more
doaj +2 more sources
Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy
Subjects with alpha-1 antitrypsin deficiency who develop pulmonary disease are managed following general treatment guidelines, including disease management interventions. In addition, administration of intravenous infusions of alpha-1 proteinase inhibitor (augmentation therapy) at regular schedules is a specific therapy for individuals with AATD with ...
Michael, Campos, Jorge, Lascano
openaire +3 more sources
Irina Petrache1, Joud Hajjar1, Michael Campos21Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA; 2Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Miller School of Medicine ...
Irina Petrache +2 more
doaj +1 more source
D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis
Jing Xia,1 Yanqiu Du,2 Jiyang Han,1 Guo Liu,1 Xumei Wang11Department of Psychiatry, Shengjing Hospital of China Medical University, Heping District Shenyang, Liaoning, People’s Republic of China; 2Department of Medicine, Shenyang Ninth People’
Xia J, Du Y, Han J, Liu G, Wang X
doaj +1 more source
Gene augmentation therapy attenuates retinal degeneration in a knockout mouse model of Fam161a retinitis pigmentosa. [PDF]
Photoreceptor cell degeneration and death is the major hallmark of a wide group of human blinding diseases including age-related macular degeneration and inherited retinal diseases such as retinitis pigmentosa. In recent years, inherited retinal diseases
Matsevich C +9 more
europepmc +2 more sources
α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy
α1 Antitrypsin deficiency (AATD) increases the risk of chronic obstructive pulmonary disease (COPD), liver disease and other conditions. Although it is not a rare disease, it is a condition rarely diagnosed because of unawareness by most healthcare ...
Michael A. Campos, Jorge Lascano
doaj +2 more sources
Cellular immunity augmentation in mainstream oncologic therapy
Anticancer immunotherapy has undergone a long evolving journey for decades, and has been dramatically applied to mainstream treatments in oncology in recent 5 years. This progress represents an advanced milestone following cytotoxic medicine and targeted
Daohong Chen, Xiaoshi Zhang
doaj +4 more sources
Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency. [PDF]
Self-administration of augmentation therapy for alpha 1-antitrypsin ...
Vianello A +14 more
europepmc +2 more sources
Atypical antipsychotics as augmentation therapy in anorexia nervosa. [PDF]
Anorexia nervosa (AN) is a life-threatening and difficult to treat mental illness with the highest mortality rates of any psychiatric disorder. We aimed to garner preliminary data on the real-world use of olanzapine and aripiprazole as augmentation ...
Enrica Marzola +5 more
doaj +3 more sources
Alpha-1 Antitrypsin Deficiency: Home Therapy
While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation ...
Anna Annunziata +5 more
doaj +1 more source

